JOHNSON & JOHNSON - 10%+ Owner at Contineum Therapeutics, Inc.

Insider Transactions and Holdings

Identity
Entity type
Company
Role
10%+ Owner
Issuer context
Issuer symbol
CTNM on Nasdaq
SEC evidence
Source filings
Open source filing history

There are no Buy or Sell transactions made by JOHNSON & JOHNSON since 31 May 2025

Holdings reported by JOHNSON & JOHNSON for Contineum Therapeutics, Inc.

Form 4 holding 10%+ Owner

Contineum Therapeutics, Inc.

Security class
Class A Common Stock
Shares / value
1,979,173
Estimated value
$33,744,900
Report date
09 Apr 2024
Price
$17.05
Ownership
Indirect

Transactions reported by JOHNSON & JOHNSON for Contineum Therapeutics, Inc.

Sym Class Transaction % Reported value Reported price Shares Shares after Date Ownership
* indicates a reported price that failed the local validity check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .